M & T Bank Corp (MTB) Falls 3.85% for January 04

Equities Staff |

One of the S&P 500’s big losers for Monday January 04 was M & T Bank Corp (MTB). The company’s stock fell 3.85% to $116.51 on volume of 746,941 shares.

The stock opened the day at 119.24 and traded between a low of $116.38 and a high of $119.24. The stock finished the day down $4.67 per share. M & T Bank Corp has an average daily volume of 1.23 million and a total float of 133.29 million shares. The 50-day SMA for M & T Bank Corp is $122.97 and its 200-day SMA is $122.37. The high for the stock over the last 52 weeks is $134.00 and the low is $111.50.

M&T Bank Corp is a New York business corporation and a bank holding company. The Company through subsidiaries provides individuals, corporations and other businesses, and institutions with commercial and retail banking services.

M & T Bank Corp is centered in Buffalo, NY, and has 15,456 employees. Today’s trading day leaves the company with a market cap of $15.53 billionwith a P/E Ratio of 16.2. The company has a P/S ratio of 4.43, P/B ratio of 1.33, and a 18.7.

For a complete fundamental analysis analysis of M & T Bank Corp, check out Equities.com’s Stock Valuation Analysis report for MTB. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Propanc Health Group Corp

Propanc Health Group Corp is an early stage healthcare company. It is engaged in developing new cancer treatments for patients, suffering from pancreatic and colorectal cancer.

Private Markets


Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…


Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…